Search Results
97 items found for "acid-base"
- Itaconate in host inflammation and defense
regulation, discuss its target proteins and mechanisms, and conjecture a rationale for developing ITA-based
- Ep 62 with Dr. Sai Prasad Pydi
Pydi's laboratory is to develop GPCR-based drugs for the treatment of obesity and Type 2 Diabetes (T2D
- Ep 89 with Dr. Patrick Sexton
Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.
- Travel Tips for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Fares are based on traffic conditions, but an average fare is $20-$30. Fares are based on traffic conditions, but an average fare is $30-$50.
- Ep 143 with Dr Davide Calebiro
To study GPCR signalling, they develop and use innovative optical methods based on FRET and single-molecule
- Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery
A GPCR activation process based on the well-discerned conformational states is thus proposed, allosterically
- Deciphering the genetic landscape of lumpy skin disease: Unraveling variable virulence through comprehensive genome sequence analysis in India
Notably, the Ankyrin repeats gene-based analysis could differentiate animals with varying clinical scores
- Ep 53 with Dr. Timo De Groof
He currently is focusing on the development of nanobody-based immuno tracers as part of the IMI/EFPIA
- Ep 95 with Chris Langmead
., a UK-based biotechnology company (2009-2012), where he was responsible all of the company’s discovery
- From odor to oncology: non-canonical odorant receptors in cancer
between these chemoreceptors and various types of cancer, potentially paving the way for innovative odor-based
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
explored as potential biomarkers and therapeutic tools for maximizing the efficiency of somatostatin-based
- Ep 87 with Dr. Bianca Plouffe
As part of Bouvier’s team, Bianca used Bioluminescence Resonance Energy Transfer (BRET)-based technology
- Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology
exploiting GPCR biased signaling to design/develop new pharmacotherapeutics to treat reward- and metabolism-based
- GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma
Thus, based on transcriptomic, proteomic, and phosphoproteomic differential expression data of GPR56
- Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation
mathematical model of a G-protein coupled receptor signaling network that is mutated in almost all cases Overall, this work highlights the power of mechanism-based computational systems biology as a discovery
- Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
Therefore, these antagonists may aid in the development of novel cancer therapeutics and patient-based
- NPFF stimulates human ovarian cancer cell invasion by upregulating MMP-9 via ERK1/2 signaling
The TaqMan probe-based RT-qPCR showed that NPFF and NPFFR2 were expressed in three human EOC cells, CaOV3
- LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice
Here, based on strong rationales, we studied the capacity of LP2 to inhibit the growth of patient-derived
- Ep 125 with Dr. Gregory Tall
mechanism by which Ric-8 proteins fold all heterotrimeric G protein alpha subunits, to exploit a Ric-8-based Mechanical dissociation of the two fragments aided by protein binding ligands and cell movement serves
- SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma
Methods: Bioinformatics analysis was performed to assess the correlation between EGFR and SSTR2 based The expression of SSTR2 and EGFR was evaluated by immunohistochemistry (IHC) in 491 cases of NPC and 50 cases of non-cancerous nasopharyngeal epithelium.
- G protein-coupled receptors: A target for microbial metabolites and a mechanistic link to microbiome-immune-brain interactions
We further mapped the distribution of these molecules across the public mass spectrometry-based metabolomics
- Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018
Data on incident cases of EC and GC during 2004 to 2018 were obtained from the Golestan Population-based Overall, 3004 new cases of EC (ASR = 15.7) and 3553 cases of GC (ASR = 18.3) were registered in the GPCR
- Systems Pharmacodynamic Model of Combination Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways
mechanisms underlying this synergistic pharmacodynamic interaction, liquid chromatography-mass spectrometry-based
- Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis
Results: Based on the risks scores, 17 GPCRRGs were associated with OV prognosis.
- Ep 60 with Dr. Josephine (Pina) Cardarelli
., based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated
- Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design
While the involvement of G-protein-coupled receptors (GPCRs) in cancer is growing, GPCR-based therapies
- Respiratory infections predominate after day 100 following B-cell maturation antigen-directed CAR T-cell therapy
One-year cumulative incidence functions were calculated based on time to first respiratory infection
- Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018
Methods: We obtained data on incidence cases of CRC from the Golestan Population-based Cancer Registry Results: Overall, 2839 new cases of CRC (ASR = 13.7) were registered in the GPCR over 2004-2018.